Is aspirin necessary in the acute phase of Kawasaki disease? - Wikidata - wikimedia - TriplyDB

Is aspirin necessary in the acute phase of Kawasaki disease?

Is aspirin necessary in the acute phase of Kawasaki disease?

http://www.wikidata.org/entity/Q47261379

about

Is aspirin necessary in the acute phase of Kawasaki disease?

http://www.wikidata.org/entity/Q47261379

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Is aspirin necessary in the acute phase of Kawasaki disease?

@en

Is aspirin necessary in the acute phase of Kawasaki disease?

@nl

type

label

Is aspirin necessary in the acute phase of Kawasaki disease?

@en

Is aspirin necessary in the acute phase of Kawasaki disease?

@nl

prefLabel

Is aspirin necessary in the acute phase of Kawasaki disease?

@en

Is aspirin necessary in the acute phase of Kawasaki disease?

@nl

P1433

Q47261379-FB3A7B28-4353-42A1-BF36-E695AC5968CE

P1476

Q47261379-E8D91346-7BBB-417F-AA6C-AABDE7888770

P2093

Q47261379-021A134C-E3BE-4227-B8AD-CDD0F1EFA304

Q47261379-217E5912-1B7C-4ABD-947D-89ED484F9F74

Q47261379-3D744BA3-AA8B-4AAF-A542-87F0CFD08186

Q47261379-56BF838E-534F-467F-B61A-16A3D498F344

Q47261379-5E6810AD-93D9-41DD-A16C-1C6CBD1ABA7A

Q47261379-842B6FD9-0573-42A8-8A49-3395AD8879B1

Q47261379-A1E9B124-2206-488B-826C-6E5319255B68

Q47261379-E211057D-3C61-47F8-B6F5-8CE5EF70F363

P2860

Q47261379-022E5205-47BE-4743-AAAF-3A57960D999C

Q47261379-22E8C12A-1C8C-4C40-BA14-EA802638AB18

Q47261379-2FC38F08-FD4C-431B-A354-D6518BDFCEB2

Q47261379-4137FFB5-646A-4EDA-BB61-2FC45E678FC5

Q47261379-434AC22C-2A68-468F-ACB7-E4F480A30146

Q47261379-5828585A-3606-4B37-B438-9962F6359FBA

Q47261379-58598AA5-7124-434B-9D21-C7B7BA076861

Q47261379-5D7E09A4-E500-4257-89D0-4F290FBCEAE6

Q47261379-8A2EF2B8-4A3F-45F3-B85A-A35C299C0E2B

Q47261379-8A61519C-30E9-415B-8741-8FBE68E547CE

P31

Q47261379-DD35F621-E720-4C04-97D5-8424BCBCBF7B

P356

Q47261379-FD6A8AAD-D93A-41F4-8203-37644D225690

P577

Q47261379-42F5CA63-D6C7-4A11-9D92-B2D8D08D1D6D

P698

Q47261379-0C1F3259-9898-45D7-B886-2E3CE314EC04

P921

Q47261379-81ACB4E0-87A2-4A9F-AFDE-29A45BA289D2

P356

P1433

Journal of Paediatrics and Child Health

P1476

Is aspirin necessary in the acute phase of Kawasaki disease?

@en

P2093

Fang Gong

http://www.w3.org/2001/XMLSchema#string

Jia Yuan

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Liling Jin

http://www.w3.org/2001/XMLSchema#string

Ping Huang

http://www.w3.org/2001/XMLSchema#string

Shuliang Xia

http://www.w3.org/2001/XMLSchema#string

Xiaofei Xie

http://www.w3.org/2001/XMLSchema#string

Xijing Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Controversies in the management of Kawasaki disease

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ

High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.

Diagnosis and therapy of Kawasaki disease in children.

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.

Is high-dose aspirin necessary in the acute phase of kawasaki disease?

Management of Kawasaki disease.

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.

An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.

P31

scholarly article

P356

10.1111/JPC.13816

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29271519

http://www.w3.org/2001/XMLSchema#string

P921